Cargando…
Hematopoietic stem cell‐ and induced pluripotent stem cell‐derived CAR‐NK cells as reliable cell‐based therapy solutions
Hematopoietic stem cell‐ (HSC) and induced pluripotent stem (iPS) cell‐derived natural killer (NK) cells containing engineered functions, such as chimeric antigen receptors (CAR), offer great promise for the treatment of seemingly incurable oncological malignancies. Today, some of the main challenge...
Autores principales: | Arias, Jonathan, Yu, Jingwei, Varshney, Mukesh, Inzunza, Jose, Nalvarte, Ivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235144/ https://www.ncbi.nlm.nih.gov/pubmed/33634954 http://dx.doi.org/10.1002/sctm.20-0459 |
Ejemplares similares
-
Hematopoietic stem cells from pluripotent stem cells: Clinical potential, challenges, and future perspectives
por: Demirci, Selami, et al.
Publicado: (2020) -
Using Pluripotent Stem Cells to Understand Normal and Leukemic Hematopoietic Development
por: Bigas, Anna, et al.
Publicado: (2022) -
Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell‐free products and human pluripotent stem cell‐derived mesenchymal stem cells
por: Wang, Li‐Tzu, et al.
Publicado: (2021) -
Optimizing allogeneic grafts in hematopoietic stem cell transplantation
por: Xu, Zheng‐Li, et al.
Publicado: (2021) -
The potential of induced pluripotent stem cells for discriminating neurodevelopmental disorders
por: Stock, Ricarda, et al.
Publicado: (2020)